Combined HRT (oestrogen + progestogen)
Estradiol with dydrogesterone
Brand names: Femoston
Adult dose
Dose: 1 tablet OD per pack regimen (sequential or continuous)
Route: Oral
Frequency: OD
Clinical pearls
- Sequential preparation for women still having periods (perimenopausal); continuous combined for ≥1 year amenorrhoea or >54 years
- Dydrogesterone progestogen: lower VTE signal in observational data vs other progestogens (BMS)
Contraindications
- Same as oestrogen + progestogen HRT — see estradiol
- Undiagnosed vaginal bleeding
- Active VTE / arterial events
- Severe liver disease
Side effects
- Breakthrough bleeding
- Breast tenderness
- Headache
- Mood changes
- VTE
- Breast cancer risk
Interactions
- CYP3A4 inducers
- Lamotrigine
Monitoring
- BP
- Bleeding diary
- Breast awareness
Reference: BNF; NICE NG23; British Menopause Society; https://bnf.nice.org.uk/drugs/estradiol-with-dydrogesterone/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
Pathways
- Spinal Anaesthesia Hypotension Management · AAGBI; ASA
- Pre-Eclampsia / Eclampsia in ED · NICE NG133; RCOG Green-top 10A
- Suspected Ectopic Pregnancy · NICE NG126; RCOG Green-top 21
- Polycystic Ovary Syndrome (PCOS) · International PCOS Guideline 2023; NICE CKS
- Pre-eclampsia Management · NICE NG133 2019
- Ectopic Pregnancy · NICE CG154 / RCOG GTG 21